7-108564663-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000415914.4(THAP5):āc.716G>Cā(p.Ser239Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000428 in 1,613,864 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S239N) has been classified as Likely benign.
Frequency
Consequence
ENST00000415914.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
THAP5 | NM_001130475.3 | c.716G>C | p.Ser239Thr | missense_variant | 3/3 | ENST00000415914.4 | NP_001123947.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
THAP5 | ENST00000415914.4 | c.716G>C | p.Ser239Thr | missense_variant | 3/3 | 1 | NM_001130475.3 | ENSP00000400500 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152194Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000478 AC: 12AN: 250816Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135732
GnomAD4 exome AF: 0.0000274 AC: 40AN: 1461552Hom.: 0 Cov.: 31 AF XY: 0.0000165 AC XY: 12AN XY: 727092
GnomAD4 genome AF: 0.000190 AC: 29AN: 152312Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74474
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 03, 2022 | The c.716G>C (p.S239T) alteration is located in exon 3 (coding exon 3) of the THAP5 gene. This alteration results from a G to C substitution at nucleotide position 716, causing the serine (S) at amino acid position 239 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at